Podcast thumbnail for Novel Androgen Deprivation Treatment for Advanced Prostate Cancer

Novel Androgen Deprivation Treatment for Advanced Prostate Cancer

Claim This Podcast

by Annenberg Center for Health Sciences

4 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation πŸ‡ΊπŸ‡Έ

Podcast Overview

Prostate cancer is the most common cancer diagnosed among men in the United States. Considered curable if diagnosed at a localized stage, the survival rate of men with metastatic disease is dramatically reduced. Due to the androgen-dependence of prostate cancer, androgen deprivation therapy (ADT) has been the mainstay and primary therapeutic approach for management of men with metastatic prostate cancer. Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of

Language

πŸ‡ΊπŸ‡²

Publishing Since

12/10/2021

1 verified contact email on file for Novel Androgen Deprivation Treatment for Advanced Prostate Cancer

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Patient Preferences

December 10, 2021

Patient Preferences

<p>Patient Preferences</p>

Episode thumbnail for Exploring Optimal Therapeutic Options

December 10, 2021

Exploring Optimal Therapeutic Options

<p>Exploring Optimal Therapeutic Options</p>

Episode thumbnail for Current State of Care in Advanced PCa

December 10, 2021

Current State of Care in Advanced PCa

<p>Current State of Care in Advanced PCa</p>

4 total episodes available

Deep-dive analytics for Novel Androgen Deprivation Treatment for Advanced Prostate Cancer

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Novel Androgen Deprivation Treatment for Advanced Prostate Cancer?

Prostate cancer is the most common cancer diagnosed among men in the United States. Considered curable if diagnosed at a localized stage, the survival rate of men with metastatic disease is dramatically reduced. Due to the androgen-dependence of prostate cancer, androgen deprivation therapy (ADT) has been the mainstay and primary therapeutic approach for management of men with metastatic prostate cancer. Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of

How often does this podcast release new episodes?

This podcast updates inactive.

Where can I listen to this podcast?

This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.